Genentech RTP Advanced Biomanufacturing Facility Groundbreaking

Deal value: $2,000,000,000

Genentech broke ground on a new advanced biomanufacturing facility in Research Triangle Park, North Carolina, designed for large-scale biologics production and featuring state-of-the-art cleanroom environments.

Genentech’s investment in the Research Triangle Park biomanufacturing facility is driven by the strategic need to expand production capacity for next-generation metabolic medicines, particularly obesity treatments. The timing aligns with surging demand for biologics, supply chain resilience priorities, and the opportunity to leverage North Carolina’s skilled workforce and life sciences ecosystem. The fundamental belief is that advanced manufacturing capabilities will accelerate delivery of innovative therapies and strengthen Genentech’s competitive position in the U.S. market.